The Board of Directors of Diplomat Pharmacy, Inc. sets high standards for the company’s employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the company's business.

Complaints or concerns related to Diplomat accounting, auditing, internal controls or financial reporting can be submitted anonymously and confidentially. For Diplomat employees or external parties wishing to access the Compliance Hotline, please refer to instructions in the "Compliance Hotline QA" document located below.

NYSE: DPLO

+0.28 +1.33% $ 21.39 Volume: 266,668 Common Stock | 20 minute delay September 26, 2017

Investor Contact

Asher S. Dewhurst

Investor Relations,
Westwicke Partners, LLC.
diplomat@westwicke.com

Phone: 443.213.0500

Email Now